Early intervention for depression and anxiety in 16-18 year olds: a multi-centre trial of self-referral psychological stress workshop programmes in schools

ISRCTN ISRCTN90912799
DOI https://doi.org/10.1186/ISRCTN90912799
ClinicalTrials.gov (NCT) Nil known
Clinical Trials Information System (CTIS) Nil known
Protocol serial number NIHR127951
Sponsor King's College London
Funder National Institute for Health Research
Submission date
28/05/2020
Registration date
02/06/2020
Last edited
02/09/2024
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Poor mental health in young people is increasing, with clear evidence of mounting psychiatric problems. However, less than a quarter of young people with mental health problems can access services, meaning there is an urgent need for easily accessible and effective mental health resources. Common barriers include the limited provision of services, reluctance of adolescents to seek professional help as well as a fear of stigmatisation.

Young people’s mental health is a major government priority, with current policy advocating the development of effective education based mental health care to prevent the escalation of mental health problems, improve access and reduce service waiting times. However, existing school-delivered programmes for depression and anxiety only have modest effects. These programmes are also mainly focused on younger children.

With these factors in mind, we have developed an accessible and non-stigmatising workshop program for older students. This award-winning programme, named DISCOVER, is a brief group workshop programme for 16 - 18-year-olds that was developed in collaboration with a Teenage Advisory Group (TAG) of 16 - 18-year-olds. DISCOVER aims to improve engagement, offer effective treatment, and maintain participants’ motivation and improvement to reduce relapse. The DISCOVER workshop is delivered in a group setting, to around 12 - 15 young people, over one school day. The workshop includes videos, discussions, and the chance to learn and practice techniques designed to improve and maintain mental wellbeing. The workshop material is organised into eight short (20 minute) sections and particular attention is paid to personal, relationship and academic worries typical for 16 - 18-year-olds. Specific methods taught include (i) Behavioural methods e.g. time management, sleep hygiene and maintaining motivation (ii) Cognitive methods e.g. learning to challenge negative thoughts and (iii) mindfulness e.g. meditation exercises. Following the workshop, to maintain progress and adherence, participants receive a DISCOVER workbook and access to a workshop-specific DISCOVER app to remind them of the methods. Participants also receive three 'follow-up' phone calls from the workshop leader to discuss how they are progressing with their personal goals.

We would like to understand whether this workshop is more effective at improving students’ mental health than the normal care they receive at school. Specifically, this clinical trial aims to answer the research question of whether the DISCOVER workshop is a clinically effective and cost-effective intervention in schools that reduces symptoms of depression in 16-18-year-olds at 3 and 6 months after the intervention.

The results of this trial will tell us whether DISCOVER is a suitable programme to take forward as a school-based mental health provision. It is very possible that DISCOVER could be a highly effective and popular component in frontline education-based mental health care as advocated by government health and education policy. We see DISCOVER fitting in very well with the current education-based mental health care aims of the government. Therefore, this trial is essential to inform the Department of Health about the effectiveness of this potentially very important intervention for 16 - 18-year-olds.

Who can participate?
The DISCOVER workshop is designed for sixth form/college students between 16 and 18 who are experiencing, or have experienced, stress or low mood problems recently. We hope this program will be helpful for as many people as possible from this group, however we are still assessing how effective it can be. It is not so suitable for young people who have very severe problems or who do not understand spoken and written English.

What does the study involve?
The study involves the comparison of two different intervention groups; the active intervention (the DISCOVER workshop) and a control intervention (normal school care). Each of the 60 schools will be randomly assigned to one of these two groups. Half of the schools (30) will receive the DISCOVER workshop and the other half (30) of schools will receive their normal care. We will assess participants' mood, stress levels and wellbeing before the intervention and at several points afterwards, in both the workshop and control groups. Following trial completion of all participants, we will then analyse this data to evaluate whether the workshop was more beneficial than the normal care students receive.

What are the possible benefits and risks of participating?
If you receive the workshop, it could help you handle stressful situations in a more helpful way, making it easier to tackle everyday problems. The DISCOVER workshop leaders will offer advice and help during the workshop and at the follow up session. However, the decision may be that your school/college will not be receiving the workshops. In which case, you will receive the normal help available from the school/college (e.g. access to websites, school counsellor). This will be helpful for us to know how students get on without receiving any extra help.

Participation does not have any likely risks associated with it. Sometimes, when we ask young people questions about their feelings, it can be mildly upsetting, but there will always be someone available for them to talk to and to provide any help needed.

Where is the study run from?
King's College London (UK). The study will be taking place in 4 sites; London, Bath, Manchester, and Northampton (London is the lead centre for the study). It will involve a total of 60 schools and 900 sixth form students.

When is the study starting and how long is it expected to run for?
January 2020 to April 2024

Who is funding the study?
National Institute for Health Research (NIHR) (UK)

Who is the main contact?
Dr Stephen Lisk, stephen.lisk@kcl.ac.uk
Dr June Brown, june.brown@kcl.ac.uk

Contact information

Dr Stephen Lisk
Scientific

King's College London
16 De Crespigny Park
Camberwell
London
SE5 8AF
United Kingdom

Phone +44 (0)20 784 80715
Email stephen.lisk@kcl.ac.uk
Dr June Brown
Public

King's College London
16 De Crespigny Park
Camberwell
London
SE5 8AF
United Kingdom

Phone +44 (0)20 78485004
Email june.brown@kcl.ac.uk

Study information

Primary study designInterventional
Study designTwo-arm blinded (researchers, analyst) multi-centre cluster randomized controlled trial
Secondary study designRandomised controlled trial
Study type Participant information sheet
Scientific titleBrief Educational workshops in Secondary Schools Trial: a multi-centre cluster randomised controlled trial of self-referral psychological stress workshops in schools for depression and anxiety in 16-18 year-olds.
Study acronymBESST
Study objectivesCurrent study hypothesis as of 22/07/2021:
1. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater reduction in symptoms of depression at 3 and 6 months
2. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater reduction in symptoms of anxiety at 3 and 6 months post-intervention
3. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater improvement in wellbeing at 3 and 6 months post-intervention
4. Cost-effectiveness of DISCOVER will be comparable to the control treatment in terms of quality adjusted life years (QALYs) at 3 and 6 months post-intervention?
5. The intervention will be considered acceptable by young people
6. What are the contextual (e.g. school) and process (e.g. workshop publicity) factors that influence implementation and clinical effectiveness?
7. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater improvement in sleep quality at 3 and 6 months post-intervention
8. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater improvement in resilience at 3 and 6 months post-intervention


Previous study hypothesis:
1. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater reduction in symptoms of depression at 3 and 6 months
2. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater reduction in symptoms of anxiety at 3 and 6 months post-intervention
3. Compared to those receiving a control intervention, participants receiving the DISCOVER workshop intervention will show greater improvement in wellbeing at 3 and 6 months post-intervention
4. Cost-effectiveness of DISCOVER will be comparable to the control treatment in terms of quality adjusted life years (QALYs) at 3 and 6 months post-intervention?
5. The intervention will be considered acceptable by young people
6. What are the contextual (e.g. school) and process (e.g. workshop publicity) factors that influence implementation and clinical effectiveness?
Ethics approval(s)Approved 28/10/2020, King's College London Research Ethics Committee (Waterloo Campus, 57 Waterloo Road London, SE1 8WA, UK; rec@kcl.ac.uk)
Health condition(s) or problem(s) studiedDepression and anxiety
InterventionParticipants in the intervention arm will receive a one-day, school-based mental health programme called the DISCOVER workshop, administered by trained NHS practitioners.
Participants in the control arm will receive normal school provision and will be offered a brief leaflet signposting them to relevant local and web-based mental health resources.
Using an online randomisation system set up by the Kings Clinical Trials Unit (CTU), schools will be randomly assigned to the intervention or control arm (1:1 allocation ratio) after students have consented and baseline data has been collected.
Intervention typeBehavioural
Primary outcome measure(s)

Symptoms of depression, measured using the Mood and Feelings Questionnaire (MFQ), collected at baseline, and 3 and 6 months post-intervention

Key secondary outcome measure(s)

Current secondary outcome measures as of 22/07/2021:
1. Symptoms of anxiety, measured using the Revised Child Anxiety and Depression Scale (RCADS), collected at baseline, and 3 and 6 months post-intervention
2. Wellbeing, measured using the Warwick Edinburgh Mental Wellbeing scale (WEMWBS), collected at baseline, and 3 and 6 months post-intervention
3. Cost-effectiveness, measured using the Child and Adolescent Service Use Schedule (CA-SUS), collected at baseline and 3 and 6 months post-intervention
4. Quality of life, measured using the EQ-5D-3L (a self-report measure of health-related quality of life, used to calculate quality-adjusted life years (QALYs) suitable for economic evaluation), collected at baseline, and 3 and 6 months post-intervention
5. Participant satisfaction, measured using the the Client Satisfaction Questionnaire, collected immediately post-intervention, and 3 and 6 months post-intervention
6. A qualitative process evaluation, designed to (a) examine the contextual and process factors that either support or obstruct the implementation of the intervention, (b) examine the experience of participants and workshop facilitators and (c) assess whether and how the contextual (e.g. school regime and environment) and process factors (e.g. publicity, component parts of the workshop) identified through this work influence the intermediary outcomes (e.g. engagement, intervention fidelity, adherence to intervention protocol) as well as the primary and secondary outcomes assessed in the trial. The qualitative process evaluation will be conducted in 8 intervention schools (following completing of follow-up measures), using semi-structured interviews (with n=16 students, n=8 workshop facilitators) and focus groups with school staff (n=8).
7. Sleep quality, measured using the Sleep Condition Indicator (SCI), collected at baseline, and 3 and 6 months post-intervention.
8. Resilience, measured using the Child and Youth Resilience Measure 12 (CYRM-12), collected at baseline, and 3 and 6 months post-intervention.


Previous secondary outcome measures:
1. Symptoms of anxiety, measured using the Revised Child Anxiety and Depression Scale (RCADS), collected at baseline, and 3 and 6 months post-intervention
2. Wellbeing, measured using the Warwick Edinburgh Mental Wellbeing scale (WEMWBS), collected at baseline, and 3 and 6 months post-intervention
3. Cost-effectiveness, measured using the Child and Adolescent Service Use Schedule (CA-SUS), collected at baseline and 3 and 6 months post-intervention
4. Quality of life, measured using the EQ-5D-3L (a self-report measure of health-related quality of life, used to calculate quality-adjusted life years (QALYs) suitable for economic evaluation), collected at baseline, and 3 and 6 months post-intervention
5. Participant satisfaction, measured using the the Client Satisfaction Questionnaire, collected immediately post-intervention, and 3 and 6 months post-intervention
6. A qualitative process evaluation, designed to (a) examine the contextual and process factors that either support or obstruct the implementation of the intervention, (b) examine the experience of participants and workshop facilitators and (c) assess whether and how the contextual (e.g. school regime and environment) and process factors (e.g. publicity, component parts of the workshop) identified through this work influence the intermediary outcomes (e.g. engagement, intervention fidelity, adherence to intervention protocol) as well as the primary and secondary outcomes assessed in the trial. The qualitative process evaluation will be conducted in 8 intervention schools (following completing of follow-up measures), using semi-structured interviews (with n=16 students, n=8 workshop facilitators) and focus groups with school staff (n=8).

Completion date01/04/2024

Eligibility

Participant type(s)Other
Age groupMixed
Lower age limit16 Years
Upper age limit18 Years
SexAll
Target sample size at registration900
Total final enrolment900
Key inclusion criteriaCurrent participant inclusion criteria as of 01/09/2023:
1. Aged between 16 - 18 years
2. Enrolled at one of the schools taking part in the trial, with planned attendance until the end of the summer term
3. Sufficient English to provide valid informed consent and complete assessments
4. Be seeking help for stress (with or without teacher encouragement)
5. Able to attend and take part in the workshop

School/college inclusion criteria:
1. Secondary school with 6th form or dedicated 6th form college
2. State-funded
3. Sufficient resources available to host trial


Previous participant inclusion criteria as of 22/07/2021 to 01/09/2023:
1. Aged between 16 - 18 years
2. Enrolled at one of the schools taking part in the trial, with planned attendance until the end of the summer term
3. Sufficient English to provide valid informed consent and complete assessments
4. Be seeking help for stress (with or without teacher encouragement)
5. Able to attend and take part in the workshop

School/college inclusion criteria:
1. Secondary school with 6th form or dedicated 6th form college
2. State-funded
3. Mixed gender
4. Sufficient resources available to host trial


Previous participant inclusion criteria:
1. Aged between 16 - 18 years
2. Enrolled at one of the schools taking part in the trial, with planned attendance until the end of the summer term
3. Sufficient English to provide valid informed consent and complete assessments
4. Be seeking help for stress (with or without teacher encouragement)
5. Able to attend and take part in the workshop
Key exclusion criteriaCurrent participant exclusion criteria as of 01/09/2023:
1. Identified as actively suicidal (through risk assessment)
2. Current involvement with Child and Adolescent Mental Health Services (reviving psychological therapy for anxiety or depression)
3. Severe learning difficulties or psychosis

School/college exclusion criteria:
1. Further education college
2. Privately funded school/college
3. 6th form/College student population <70


Previous participant exclusion criteria as of 27/09/2022 to 01/09/2023:
1. Identified as actively suicidal (through risk assessment)
2. Current involvement with Child and Adolescent Mental Health Services
3. Severe learning difficulties or psychosis

School/college exclusion criteria:
1. Further education college
2. Single-gender school/college
3. Privately funded school/college
4. 6th form/College student population <70


Previous participant exclusion criteria as of 22/07/2021:
1. Identified as actively suicidal (through risk assessment)
2. Current involvement with Child and Adolescent Mental Health Services
3. Current involvement with school counselling
4. Severe learning difficulties or psychosis

School/college exclusion criteria:
1. Further education college
2. Single-gender school/college
3. Privately funded school/college
4. 6th form/College student population <70


Previous participant exclusion criteria:
1. Identified as actively suicidal (through risk assessment)
2. Current involvement with Child and Adolescent Mental Health Services
3. Current involvement with school counselling
4. Severe learning difficulties or psychosis
Date of first enrolment01/09/2021
Date of final enrolment01/12/2022

Locations

Countries of recruitment

  • United Kingdom
  • England

Study participating centres

King's College London
Institute of Psychiatry, Psychology and Neuroscience (IoPPN)
16 De Crespigny Park
Camberwell
London
SE5 8AF
United Kingdom
The University of Manchester
Oxford Rd
Manchester
M13 9PL
United Kingdom
University of Bath
Claverton Down
Bath
BA2 7AY
United Kingdom
University of Northampton
Waterside Campus
University Drive
Northampton
NN1 5PH
United Kingdom

Results and Publications

Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
IPD sharing planThe current data sharing plans for this study are unknown and will be available at a later date.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article 04/05/2024 07/05/2024 Yes No
Results article Clinical effectiveness and cost-effectiveness 13/05/2024 20/05/2024 Yes No
Protocol article 09/11/2022 11/11/2022 Yes No
Other publications Secondary analysis 29/08/2024 02/09/2024 Yes No
Participant information sheet Participant information sheet 11/11/2025 11/11/2025 No Yes
Study website Study website 11/11/2025 11/11/2025 No Yes

Editorial Notes

02/09/2024: Publication reference added.
20/05/2024: Publication reference added.
07/05/2024: Publication reference added.
13/12/2023: The recruitment start date was changed from 01/09/2020 to 01/09/2021. Total final enrolment added.
01/09/2023: The following changes have been made:
1. The participant inclusion criteria were changed.
2. The participant exclusion criteria were changed.
3. The intention to publish date was changed from 01/09/2023 to 01/04/2024.
11/11/2022: Publication reference added.
27/09/2022: The exclusion criteria were changed.
27/09/2022: The intention to publish date was changed from 01/09/2022 to 01/09/2023.
22/07/2021: The following changes have been made:
1. The ethics approval has been added.
2. The study hypothesis has been updated.
3. The secondary outcome measures have been updated.
4. The participant inclusion criteria have been updated.
5. The participant exclusion criteria have been updated.
6. The trial website has been added.
28/05/2020: Trial’s existence confirmed by NIHR HTA